Sourcebio International (LON:SBI) Stock Price Up 4.5% – Should You Buy?

Sourcebio International Plc (LON:SBI) shares traded up 4.5% on Wednesday . The company traded as high as GBX 125 ($1.58) and last traded at GBX 115 ($1.46). 1,571,282 shares traded hands during mid-day trading, an increase of 931% from the average session volume of 152,444 shares. The stock had previously closed at GBX 110 ($1.39).

Sourcebio International Stock Up 4.5 %

The company has a debt-to-equity ratio of 35.10, a quick ratio of 1.78 and a current ratio of 1.91. The firm has a fifty day simple moving average of GBX 115 and a 200-day simple moving average of GBX 115. The firm has a market cap of £85.31 million and a price-to-earnings ratio of 1,277.78.

About Sourcebio International

Sourcebio International Plc, together with its subsidiaries, provides various laboratory services and products to clients in the healthcare, clinical, life science research, and biopharma industries in the United Kingdom, Europe, the United States, and internationally. The company's services cover histopathology cancer screening and clinical diagnostic services; DNA sequencing services and precision medicine to pharmaceutical and biotechnology companies, academia, contract research organizations, and other research markets; shelf-life testing services and equipment; and COVID-19 antigen PCR testing services.